StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > West to Safeway Pharmacy Yesterday

<< Previous

Bullboard Posts

Next >>

Comment by Liked2Thinkon May 12, 2022 1:19pm

112 Views

Post# 34678430

RE:RE:RE:RE:West to Safeway Pharmacy Yesterday

yeah they made money early on

These little kits that the pumpers raved about when they came out though has made them zero. No one needed them when they came out. Borderpass was pointless on arrival.

They have plowed through their covid revenue of which they never did their 1,000 tests per day "capactiy" and for some reason were working to move to a higher 2-3,000 test per day capactiy.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing